128 related articles for article (PubMed ID: 22664026)
1. TH17 cells are critical for skin-specific pathological injury in acute graft-versus-host disease.
Cheng H; Tian J; Li Z; Zeng L; Pan B; Song G; Chen W; Xu K
Transplant Proc; 2012 Jun; 44(5):1412-8. PubMed ID: 22664026
[TBL] [Abstract][Full Text] [Related]
2. Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation.
Cheng H; Tian J; Zeng L; Pan B; Li Z; Song G; Chen W; Xu K
Hematology; 2012 Sep; 17(5):261-7. PubMed ID: 22971531
[TBL] [Abstract][Full Text] [Related]
3. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
[TBL] [Abstract][Full Text] [Related]
4. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
6. Altered balance between Th1 and Th17 cells in circulation is an indicator for the severity of murine acute GVHD.
Pan B; Zeng L; Cheng H; Song G; Chen C; Zhang Y; Li Z; Xu K
Immunol Lett; 2012 Feb; 142(1-2):48-54. PubMed ID: 22249079
[TBL] [Abstract][Full Text] [Related]
7. [The role of Th17 cells in early onset of mice acute graft versus host disease].
Cheng H; Zeng LY; Pan B; Song GL; Tian J; Chen C; Yan ZL; Li ZY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):322-5. PubMed ID: 21729601
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
[TBL] [Abstract][Full Text] [Related]
9. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
10. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
12. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
[TBL] [Abstract][Full Text] [Related]
13. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
Zhao XY; Xu LL; Lu SY; Huang XJ
Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
[TBL] [Abstract][Full Text] [Related]
14. [Significance of Th1/Th17 Imbalance in Mice with Acute Graft-versus-Host Disease].
Yao Y; Pan B; Bian YP; Xia DD; Cheng H; Song GL; Zeng LY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1488-92. PubMed ID: 26524063
[TBL] [Abstract][Full Text] [Related]
15. A two-phase pathogenesis of graft-versus-host disease in mice.
van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
[TBL] [Abstract][Full Text] [Related]
16. [Blockage of Th17 cells differentiation exacerbated mouse acute intestine graft-versus-host disease following allogeneic bone marrow transplantation].
Li HJ; Cheng H; Pan B; Zeng LY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1024-7. PubMed ID: 23363796
[TBL] [Abstract][Full Text] [Related]
17. Adoptively transferred donor IL-17-producing CD4
Cai Y; Ma S; Liu Y; Gong H; Cheng Q; Hu B; Wu Y; Yu X; Dong C; Sun K; Wu D; Liu H
Cell Mol Immunol; 2018 Mar; 15(3):233-245. PubMed ID: 27748733
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
20. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
